Teenage and Young Adult Trials Advisory Group
Our teenage young adult trials advisory group helps raise awareness of clinical trials for young people aged 16–24 who are affected by cancer.
What does this advisory group do?
This group provides an online forum to discuss complex patient cases and identify the most suitable treatment or trial referral pathways available.
The advisory group includes clinicians with specialist expertise in cancers affecting teenagers and young adults (TYA). It works alongside existing local and regional multidisciplinary teams, adding disease-specific expertise in the most prevalent TYA cancers.
If you are a healthcare professional responsible for identifying trials for patients and have a question for the group, please submit our form to ecmcadmin@cancer.org.uk.
Benefits of the group
Improves trial access to TYA patients.
Increases the opportunity for identifying trial and referrals, including those hard to recruit for.
Enhances TYA patient recruitment numbers and timelines.
Additional support and resources
TYA research website for patients
Useful age-appropriate learning resource to share with your teenage and young adult patients to help demystify clinical trials, biobanking and genomics.
TYA clinical research roadmap
We developed a roadmap that sets out how we can improve access to clinical trials and outcomes for teenagers and young adults affected by cancer.
You might also be interested in
Paediatric network
Our 12 paediatric centres bring together clinicians and translational scientists to run early-phase clinical trials for children and young people affected by cancer.
TYA Network Group
This group shares ongoing TYA projects and initiatives, explore challenges and strengthen collaboration across the network.
Sign up to our newsletter
Be the first to hear about the latest network news, events and opportunities with our monthly newsletter.